Year: 2024

PRESS RELEASE                                         Share Buyback Transaction Details October 31 – November 6, 2024 Alphen aan den Rijn – November 7, 2024 – Wolters Kluwer (Euronext: WKL), a global leader in professional information, software solutions, and services, today reports that it has repurchased 112,600 of its own ordinary shares in the period from October 31, 2024, up to and including November 6, 2024, for €17.8 million and at an average share price of €158.01. These repurchases are part of the share buyback program announced on February 21, 2024, under which we intend to repurchase shares for €1 billion during 2024. The cumulative amounts repurchased in the year to date under this program are as follows: Share Buyback 2024Period Cumulative shares repurchased in period Total consideration(€ million) Average share...

ZUG, Switzerland, Nov. 07, 2024 (GLOBE NEWSWIRE) —Significant advancement on product portfolio, including enrollment in the OCS-01 DIAMOND Phase 3 program in DME and OCS-05 Phase 2 ACUITY trial in acute optic neuritis (AON) with topline readout anticipated in December 2024 Leadership team bolstered with extensive experience in key areas as the Company advances its late-stage pipeline and prepares for commercial phase Cash, cash equivalents and short-term investments of $125.0 million as of September 30, 2024, provides cash runway into 2H 2026Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced results for the quarter ended September 30, 2024, and provided an overview of the Company’s progress. Riad...

Significant advancement on product portfolio, including enrollment in the OCS-01 DIAMOND Phase 3 program in DME and OCS-05 Phase 2 ACUITY trial in acute optic neuritis (AON) with topline readout anticipated in December 2024 Leadership team bolstered with extensive experience in key areas as the Company advances its late-stage pipeline and prepares for commercial phase Cash, cash equivalents and short-term investments of $125.0 million as of September 30, 2024, provides cash runway into 2H 2026ZUG, Switzerland, Nov. 07, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced results for the quarter ended September 30, 2024, and provided an overview of the Company’s progress. Riad Sherif...

SHANGHAI, China, Nov. 07, 2024 (GLOBE NEWSWIRE) — Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading Credit-Tech platform in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2024, after U.S. markets close on Tuesday, November 19, 2024. Qifu Technology’s management team will host an earnings conference call at 7:30 PM U.S. Eastern Time on Tuesday, November 19, 2024 (8:30 AM Beijing Time on Wednesday, November 20, 2024). Conference Call Preregistration All participants wishing to join the conference call must pre-register online using the link provided below. Registration Link: https://register.vevent.com/register/BI019bc78618c84e7184e794d691cfdb5b Upon registration, each participant will receive details for the conference...

2025 FINANCIAL CALENDAR Paris, 7 November 2024 Full-year results and Q4 2024 sales: 26 March 2025*Quiet period: from 12 to 26 March 2025Q1 2025 sales: 3 June 2025*Quiet period: from 20 May to 3 June 2025Annual General Meeting: 13 June 2025 Half-year results and Q2 2025 sales: 24 September 2025*Quiet period: from 10 to 24 September 2025Q3 2025 sales: 2 December 2025*Quiet period: from 18 November to 2 December 2025* Publication after the closing of the Premier Marché of Euronext Paris About Quadient®Quadient is a global automation platform provider powering secure and sustainable business connections through digital and physical channels. Quadient supports businesses of all sizes in their digital transformation and growth journey, unlocking operational efficiency and creating meaningful customer experiences. Listed in...

Strong financial performance driven by Sea Based AKVA group delivered high quarterly revenue in Q3 2024 of MNOK 1,011 (817). Adjusted for the gain of MNOK 76 related to the Observe transaction, the revenue was MNOK 936 and 14,5% higher compared to Q3 2023. EBITDA was MNOK 199 in Q3 2024. Adjusted for the net gain of NOK 71 related to the Observe transaction EBITDA was MNOK 128 compared to MNOK 78 in Q3 2023. Total order intake of MNOK 803 (600) in Q3 2024 and order backlog was BNOK 2,4 at the end of September 2024. Completion of the acquisition of Observe Technologies at the start of Q3, increasing ownership from 33.7% to 100%. Awarded LOI from Cermaq early Q4 related to RAS contract for new post smolt facility in Chile with estimated contract value of MEUR 30. The high activity is driven by the Sea Based business segment and continued...